New study targets tough heart valve cases with advanced device
NCT ID NCT07450196
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how safe and effective the SAPIEN 3 heart valve is for people with a certain type of bicuspid aortic valve stenosis (Type-0). About 170 people in China will be observed after the procedure to track serious problems like death, stroke, or rehospitalization. The goal is to see if this valve works well for this challenging anatomy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chinese Academy of Medical Sciences, Fuwai Hospital, Beijing
Beijing, Beijing Municipality, 100037, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Heart valve fix without the hospital stay? trial tests Same-Day discharge
- Can a wearable monitor prevent heart emergencies after valve replacement?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.
- Could a heart pill delay valve replacement?
- Blood test could predict clot risk after heart valve surgery